Status:
TERMINATED
ODEN Trial: Option vs. Denali IVC Filters
Lead Sponsor:
University of California, San Francisco
Conditions:
Venous Thromboembolism
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This research study is a prospective randomized trial evaluating the relative safety of two inferior vena cava (IVC) filters used to prevent the migration of potentially dangerous deadly blood clots f...
Detailed Description
This is a prospective, randomized trial comparing two FDA-approved inferior vena cava filters, the Denali retrievable IVC filter (Bard Peripheral Vascular Inc., Tempe, AZ) and the Option Elite (Argon ...
Eligibility Criteria
Inclusion
- Patients scheduled for IVC filter placement at UCSF Moffitt, Mission Bay and Mount Zion hospitals Interventional Radiology
- 18+
Exclusion
- Necessity of permanent IVC filter.
- Genetic or physical abnormalities of the inferior vena cava
- Circumstances that in the opinion of the primary investigator, patient would be a poor candidate either due to complications in medical condition or lack of ability for follow up.
Key Trial Info
Start Date :
May 27 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 27 2018
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT02201277
Start Date
May 27 2014
End Date
April 27 2018
Last Update
September 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSF Medical Center
San Francisco, California, United States, 94143